-75.2%
PATH vs CHTR
-79.9%
+4.7%
-83.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CHTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | +4.3% | -3.0% | -0.2% |
| 7D | +2.1% | +17.2% | -15.1% | -3.9% |
| 30D | +1.6% | +31.6% | -30.0% | -9.0% |
| 3M | -20.4% | -11.6% | -8.9% | -18.0% |
| 6M | +40.1% | -3.3% | +43.4% | +37.9% |
| YTD | -19.0% | -33.7% | +14.7% | -11.1% |
| 1Y | -5.8% | -32.4% | +26.6% | +2.4% |
| 3Y | -22.9% | -65.9% | +43.0% | +9.8% |
| All | -75.2% | -79.9% | +4.7% | -47.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CHTR.
Daily Out/Under-Performance
Portfolio return minus CHTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CHTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling